Drugs - PowerPoint PPT Presentation

1 / 17
About This Presentation
Title:

Drugs

Description:

... tubular damage bisphosphonate regeneration signal cisplatin proliferation proliferation blocked abortive regeneration back leak syndrome renal insufficiency ... – PowerPoint PPT presentation

Number of Views:16
Avg rating:3.0/5.0
Slides: 18
Provided by: Hopf
Category:
Tags: cisplatin | drugs

less

Transcript and Presenter's Notes

Title: Drugs


1
Drugs Kidney
  • Helmut Hopfer
  • Basel, Switzerland

2
Patterns of Drug-induced Lesions
  • Tubulointerstitium
  • Acute tubular injury
  • - Osmotic nephrosis
  • - Nephrocalcinosis
  • - Chrystal NP
  • Acute interstitial nephritis
  • Chronic tubulointer- stitial nephropathy

Glomeruli Minimal change disease Focal
segmental glomerulosclerosis Membranous
GN Crescentic GN Thrombotic micro- angiopathy
Blood vessels Hyalinosis Thrombotic
micro- angiopathy Vasculitis
3
Patterns of Drug-induced Lesions
  • Tubulointerstitium
  • Acute interstitial nephritis
  • Chronic tubulointer- stitial nephropathy
  • Acute tubular injury
  • - Osmotic nephrosis
  • - Nephrocalcinosis
  • - Chrystal NP

Glomeruli Minimal change disease Focal
segmental glomerulosclerosis Membranous
GN Crescentic GN Thrombotic micro- angiopathy
Blood vessels Hyalinosis Thrombotic
micro- angiopathy Vasculitis
4
Problems
  • Case reports or small case series
  • Incomplete clinical data at time of biopsy
  • Difficulty establishing cause - effect
    relationships
  • Patterns are usually not specific for a certain
    drug
  • Some drugs may cause various patterns

5
Example Zoledronate
  • Intravenous nitrogen-containing BP
  • Hypercalcemia, esp. multiple myeloma and bone
    metastasis in solid tumors
  • Binding to bone, osteoclast inhibition after
    localized release
  • Inhibition of farnesyl diphospha-tate synthase ?
    inhibition of small GTPases involved in cell
    signaling

6
Renal Handling of Bisphosphonates
glomerular filtration
7
  • Glomerular pathology in BPs
  • FSGS, collapsing variant, also NOS
  • minimal change disease
  • Pamidronate
  • Zoledronate
  • Alendronate

8
Nach Kino et al., Biopharm Drug Dispos 20 193,
1999 T. Pfister, Roche
9
Nach Kino et al., Biopharm Drug Dispos 20 193,
1999
10
(No Transcript)
11
KI67
NaK-ATPase
Markowitz et al., Kidney Int 64281, 2003
12
Goscinny and Uderzo, 1969
13
(No Transcript)
14
Renal Zoledronate Toxicity
  • Risk factors for kidney injury
  • Multiple myeloma or RCC vs. other basic diseases
  • Increased age
  • Number of doses
  • Current use of NSAID
  • Current or prior use of cisplatin
  • McDermott et al., J Support Oncol 4524, 2006

15
time (h)
bisphosphonate
tubular damage
regeneration signal
renal recovery
proliferation
proliferation blocked
abortive regeneration
back leak syndrome
renal insufficiency
cisplatin
16
Summary
  • Multiple drugs cause common patterns of renal
    pathology
  • Tubules are most frequently affected due to
    tubular secretion
  • Important risk factors are preexisting renal
    diseases and concomitant use of other potentially
    nephrotoxic drugs
  • Alertness and awareness of the renal patho-logist
    are a key prerequisite for identification

17
Drugs Kidney Literature
  • Perazella MA, Markowitz GS Bisphosphonate
    nephrotoxicity. Kidney Int 741385-1393, 2008
  • Markowitz GS, Perazella MA Drug-induced renal
    failure a focus on tubulo-intestitial disease.
    Clin Chim Acta 35131-47, 2005
  • John R, Herzenberg AM Renal toxicity of
    therapeutic drugs. J Clin Pathol 62505-515, 2009
Write a Comment
User Comments (0)
About PowerShow.com